12:00 AM
 | 
Aug 20, 2007
 |  BioCentury  |  Finance

Amgen's anemia sales

Amgen's anemia sales

Amgen's anemia sales
Amgen's anemia drug sales could have been $6 billion last year - instead of the actual $6.6 billion AMGN recorded - if the recent national coverage decision by the Centers for Medicare & Medicaid Services (CMS) had been in place. The...

Read the full 237 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >